Managing Depressive Symptoms in ADPKD
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-70
SponsorMayo Clinic
About this trial
The purpose of this research is to evaluate the feasibility and effectiveness of Digital Neurotherapy (DNT) or Capacity Coaching (CC) for managing symptoms of depression and self reported pain in Autosomal Dominant Polycystic Kidney Disease (ADPKD) compared to education alone.
Eligibility criteria
Qualifiers
Confirmed clinical diagnosis of ADPKD using Pei-Ravine criteria
Pre-End Stage Kidney Disease, with Stage 1-5 CKD (eGFR >10 ml/min/1.73m2, with no anticipated dialysis or transplant within 12 months)
Clinical or self-diagnosis of depression
English-language fluency
Disqualifiers
Suicidal ideation/unstable mental illness of any kind
Lack of access/ability to use internet-based programs
eGFR <10 ml/min/1.73m2
Anticipated dialysis or transplant within 6 months
Trial design
Treatments tested in this trial
- Mayo Clinic-Approved Education
- Digital Neuropathy
- Capacity Coaching
Treatment groups
105 Participants
are divided into 3 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov